Fair (present) value, imo, for this stock is at least AUD$125 (P/E of ~35).
http://annualreport.csl.com.au/year-in-review/financial-highlights.htm
- Unprecidented investment in R&D that will yield monopolising outcome results.
- Asia currently makes up merely 11% (Australia = 8%)!
- Seqirus makes up 11% of revenue only (flu on the rise as we urbanise as a species).
- Share buy back just around the corner.
- ROE of ~40%!
- EBITDA margin of 27%!
- YoY Revenue growth (FY15 vs. FY16) of 9%.
- Cashed coming out of their ears for aquisitions.
CSL Decline, page-146
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$301.12 |
Change
0.350(0.12%) |
Mkt cap ! $145.5B | |||
| Open | High | Low | Value | Volume |
| $301.69 | $304.00 | $298.71 | $230.4M | 764.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 32 | $301.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $301.13 | 937 | 1 |
View Market Depth
| Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
| CSL (ASX) Chart |